|
1
|
Ding Z, Kim S, Dorsam RT, Jin J and
Kunapuli SP: Inactivation of the human P2Y12 receptor by thiol
reagents requires interaction with both extracellular cysteine
residues, Cys17 and Cys270. Blood. 101:3908–3914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alwan A: Global status report on
noncommunicable diseases 2010. World Health Organization; Geneva:
2010
|
|
3
|
Mendis S, Puska P and Norrving B: Global
Atlas on cardiovascular disease prevention and control. World
Health Organization in collaboration with the World Heart
Federation and the World Stroke Organization; Geneva: 2011
|
|
4
|
Angiolillo DJ, Fernandez-Ortiz A, Bernardo
E, et al: Identification of low responders to a 300-mg clopidogrel
loading dose in patients undergoing coronary stenting. Thrombosis
Res. 115:101–108. 2005. View Article : Google Scholar
|
|
5
|
Antman EM, Hand M, Armstrong PW, et al:
2007 focused update of the ACC/AHA 2004 guidelines for the
management of patients with ST-elevation myocardial infarction: a
report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines: developed in
collaboration with the Canadian Cardiovascular Society endorsed by
the American Academy of Family Physicians: 2007 Writing Group to
review new evidence and update the ACC/AHA 2004 guidelines for the
management of patients with ST-elevation myocardial infarction,
writing on behalf of the 2004 Writing Committee. Circulation.
117:296–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hulot JS, Bura A, Villard E, et al:
Cytochrome P450 2C19 loss-of-function polymorphism is a major
determinant of clopidogrel responsiveness in healthy subjects.
Blood. 108:2244–2247. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sibbing D, Stegherr J, Latz W, et al:
Cytochrome P450 2C19 loss-of-function polymorphism and stent
thrombosis following percutaneous coronary intervention. Eur Heart
J. 30:916–922. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brandt JT, Close SL, Iturria SJ, et al:
Common polymorphisms of CYP2C19 and CYP2C9 affect the
pharmacokinetic and pharmacodynamic response to clopidogrel but not
prasugrel. J Throm Haemost. 5:2429–2436. 2007. View Article : Google Scholar
|
|
9
|
Giusti B, Gori AM, Marcucci R, et al:
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4
IVS10 + 12 G/A and P2Y12 T744C polymorphisms, is associated with
response variability to dual antiplatelet treatment in high-risk
vascular patients. Pharmacogenet Genom. 17:1057–1064. 2007.
View Article : Google Scholar
|
|
10
|
Trenk D, Hochholzer W, Fromm MF, et al:
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel
platelet reactivity associated with adverse 1-year clinical outcome
of elective percutaneous coronary intervention with drug-eluting or
bare-metal stents. J Am Coll Cardiol. 51:1925–1934. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fontana P, Senouf D and Mach F: Biological
effect of increased maintenance dose of clopidogrel in
cardiovascular outpatients and influence of the cytochrome P450
2C19*2 allele on clopidogrel responsiveness. Thromb Res.
121:463–468. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferreiro JL and Angiolillo DJ: Clopidogrel
response variability: current status and future directions. Thromb
Haemost. 102:7–14. 2009.PubMed/NCBI
|
|
13
|
Chan MY: Clopidogrel pharmacogenetics of
east, south and other Asian populations. Euro Heart J Suppl.
14:A41–A42. 2012. View Article : Google Scholar
|
|
14
|
Rehman K, Tariq MA and Akhtar T:
Clopidogrel resistance and its genetics. Pak Heart J. 46:151–158.
2013.
|
|
15
|
Abid L, Laroussi L, Bahloul A, Siala A,
Abdelhédi R, Kharrat N, Hentati M and Kammoun S: Impact of
cytochrome P450 2C19*2 polymorphism on the clinical cardiovascular
events after stent implantation in patients receiving clopidogrel
of a southern Tunisian region. World J Cardiovasc Dis. 3:4–10.
2013. View Article : Google Scholar
|
|
16
|
Hirotsu N, Murakami N, Kashiwagi T, Ujiie
K and Ishimaru K: Protocol: a simple gel-free method for SNP
genotyping using allele-specific primers in rice and other plant
species. Plant Methods. 6:122010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aynacioglu AS, Sachsc C, Bozkurt A, et al:
Low frequency of defective alleles of cytochrome P450 enzymes 2C19
and 2D6 in the Turkish population. Clin Pharmacol Ther. 66:185–192.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamba JK, Dhiman RK and Kohli KK: Genetic
polymorphism of the hepatic cytochrome P450 2C19 in north Indian
subjects. Clin Pharmacol Ther. 63:422–427. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ozawa S, Soyama A, Saeki M, et al: Ethnic
differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and
MDR1/ABCB1. Drug Metabol Pharmacokinet. 19:83–95. 2004. View Article : Google Scholar
|
|
20
|
Zand N, Tajik N, Moghaddam AS and Milanian
I: Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in
a healthy Iranian population. Clin Exp Pharmacol Physiol.
34:102–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sukasem C, Tunthong R, Chamnanphon M, et
al: CYP2C19 polymorphisms in the Thai population and the clinical
response to clopidogrel in patients with atherothrombotic-risk
factors. Pharmgenomics Pers Med. 6:85–91. 2013.PubMed/NCBI
|
|
22
|
Hodgkinson A and Eyre-Walker A: Human
triallelic sites: evidence for a new mutational mechanism?
Genetics. 184:233–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coulondre C, Miller JH, Farabaugh PJ and
Gilbert W: Molecular-basis of base substitution hotspots in
Escherichia coli. Nature. 274:775–780. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Blake RD, Hess ST and Nicholson-Tuell J:
The influence of nearest neighbors on the rate and pattern of
spontaneous point mutations. J Mol Evol. 34:189–200. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Z, Fu YX, Hewett-Emmett D and
Boerwinkle E: Investigating single nucleotide polymorphism (SNP)
density in the human genome and its implications for molecular
evolution. Gene. 312:207–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang DG and Green P: Bayesian Markov
chain Monte Carlo sequence analysis reveals varying neutral
substitution patterns in mammalian evolution. Proc Natl Acad Sci
USA. 101:13994–14001. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bird AP: DNA methylation and the frequency
of CpG in animal DNA. Nucleic Acids Res. 8:1499–1504. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mega JL, Close SL, Wiviott SD, et al:
Cytochrome P-450 polymorphisms and response to clopidogrel. New
Engl J Med. 360:354–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jinnai T, Horiuchi H, Makiyama T, et al:
Impact of CYP2C19 polymorphisms on the antiplatelet effect of
clopidogrel in an actual clinical setting in Japan. Circ J.
73:1498–1503. 2009. View Article : Google Scholar : PubMed/NCBI
|
